Clin Immunol
-
Publication Venue For
- Cellular changes in eculizumab early responders with generalized myasthenia gravis.. 231:108830. 2021
- The interaction of anti-DNA antibodies with DNA antigen: Evidence for hysteresis for high avidity binding.. 231:108848. 2021
- The potential impact of timing of IVIG administration on the efficacy of rituximab for immune tolerance induction for patients with Pompe disease.. 219:108541. 2020
- The binding of SLE autoantibodies to mitochondria.. 212:108349. 2020
- Morbidity in an adenosine deaminase-deficient patient during 27 years of enzyme replacement therapy.. 211:108321. 2020
- Initial safety analysis of a randomized phase II trial of nelipepimut-S + GM-CSF and trastuzumab compared to trastuzumab alone to prevent recurrence in breast cancer patients with HER2 low-expressing tumors.. 201:48-54. 2019
- HLA- and genotype-based risk assessment model to identify infantile onset pompe disease patients at high-risk of developing significant anti-drug antibodies (ADA).. 200:66-70. 2019
- IL-11 antagonist suppresses Th17 cell-mediated neuroinflammation and demyelination in a mouse model of relapsing-remitting multiple sclerosis.. 197:45-53. 2018
- Patients with core antibody positive and surface antigen negative Hepatitis B (anti-HBc+, HBsAg-) on anti-TNF therapy have a low rate of reactivation.. 191:59-62. 2018
- Reversibility of peripheral blood leukocyte phenotypic and functional changes after exposure to and withdrawal from tofacitinib, a Janus kinase inhibitor, in healthy volunteers.. 191:10-20. 2018
- The role of monogamous bivalency and Fc interactions in the binding of anti-DNA antibodies to DNA antigen.. 166-167:38-47. 2016
- A role for plasma cell targeting agents in immune tolerance induction in autoimmune disease and antibody responses to therapeutic proteins.. 165:55-59. 2016
- Combined immunodeficiency in the United States and Kuwait: Comparison of patients' characteristics and molecular diagnosis.. 161:170-173. 2015
- Effects of enzyme replacement therapy on immune function in ADA deficiency patient.. 161:391-393. 2015
- Cellular and molecular targeting for nanotherapeutics in transplantation tolerance.. 160:14-23. 2015
- The role of fractalkine (CX3CL1) in regulation of CD4(+) cell migration to the central nervous system in patients with relapsing-remitting multiple sclerosis.. 157:121-132. 2015
- The role of antigen specificity in the binding of murine monoclonal anti-DNA antibodies to microparticles from apoptotic cells.. 154:178-187. 2014
- Humoral immunity induced by mucosal and/or systemic SIV-specific vaccine platforms suggests novel combinatorial approaches for enhancing responses.. 153:308-322. 2014
- The effect of polyamines on the binding of anti-DNA antibodies from patients with SLE and normal human subjects.. 153:94-103. 2014
- The role of microparticles in the generation of immune complexes in murine lupus.. 146:1-9. 2013
- The origin and properties of extracellular DNA: from PAMP to DAMP.. 144:32-40. 2012
- Chronic rotavirus infection in an infant with severe combined immunodeficiency: successful treatment by hematopoietic stem cell transplantation.. 142:399-401. 2012
- Thymic microenvironment reconstitution after postnatal human thymus transplantation.. 140:244-259. 2011
- Thymus transplantation.. 135:236-246. 2010
- T cell large granular lymphocyte leukemia associated with rheumatoid arthritis and neutropenia.. 132:145-152. 2009
- G-CSF induces a potentially tolerant gene and immunophenotype profile in T cells in vivo.. 132:83-92. 2009
- Immunologic reconstitution during PEG-ADA therapy in an unusual mosaic ADA deficient patient.. 130:162-174. 2009
- Oligoclonal myelin-reactive T-cell infiltrates derived from multiple sclerosis lesions are enriched in Th17 cells.. 130:133-144. 2009
- Estradiol regulates MICA expression in human endometrial cells.. 129:325-332. 2008
- Granulocyte chemotaxis and disease expression are differentially regulated by GRK subtype in an acute inflammatory arthritis model (K/BxN).. 129:115-122. 2008
- Inflammatory bowel disease following solid organ transplantation.. 128:287-293. 2008
- Bromelain treatment decreases neutrophil migration to sites of inflammation.. 128:66-74. 2008